MEVAC Avian Influenza Vaccine

MEVAC Avian Influenza Vaccine is a veterinary biologic developed by Middle East for Vaccines (MEVAC) for the active immunization of poultry against avian influenza virus. The vaccine is typically an inactivated, oil-emulsified formulation designed to induce a robust humoral immune response, specifically targeting the hemagglutinin protein of the virus. This prevents or reduces the severity of clinical disease and decreases viral shedding in infected birds. MEVAC, an American-Egyptian joint venture, tailors these vaccines to the specific epidemiological needs of the Middle East and African regions, often covering highly pathogenic (H5) and low pathogenic (H9) strains.

Brand names

MEVAC AIMEVAC FLU

Other names

Avian Influenza Vaccine (Poultry)